Shenogen Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 186
Employees
  • Latest Deal Type
  • IPO
  • (Announced)
  • Latest Deal Amount
  • $285M
Latest Deal Amount
  • Investors
  • 33

Shenogen General Information

Description

Developer of therapeutics for autoimmune diseases and cancer treatment. The company's therapeutics for cancer treatment utilizes membrane-bound estrogen receptors for the treatment of cancer, enabling patients to receive treatment and drugs for cancer and autoimmune diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Zhongguancun Life Science Park
  • Changping District
  • Beijing
  • China
+86 010 0000 0000

Shenogen Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. IPO 30-May-2020 $285M 00000 Announced Generating Revenue/Not Profitable
9. Later Stage VC (Series E3) 01-Dec-2019 0000 00000 00000 Completed Generating Revenue/Not Profitable
8. Later Stage VC (Series E2) 01-Mar-2019 0000 00000 00000 Completed Generating Revenue/Not Profitable
7. Later Stage VC (Series E) 01-Sep-2017 0000 00000 00000 Completed Clinical Trials - General
6. Later Stage VC (Series D) 29-Jul-2016 0000 000.00 00000 Completed Clinical Trials - General
5. Secondary Transaction - Private 000.00 Completed Clinical Trials - General
4. Later Stage VC (Series C) 01-Aug-2013 000.00 000.00 0000 Completed Clinical Trials - General
3. Early Stage VC (Series B) 01-Aug-2010 00.00 00.00 Completed Startup
2. Early Stage VC (Series A) 01-Jan-2008 $1.6M $1.9M Completed Startup
1. Angel (individual) 01-Sep-2007 $300K $300K Completed Startup
To view Shenogen’s complete valuation and funding history, request access »

Shenogen Executive Team (12)

Name Title Board Seat Contact Info
Kun Meng Ph.D Co-Founder, Chief Executive Officer & Chairman
Larry Zhang Ph.D Chief Operating Officer, Chief Technology Officer & Board Member
Zhaoyi Wang Ph.D Co-Founder, Chief Science Officer & Board Member
Jun Bao Ph.D Senior Vice President, Chief Business Officer and Board Member
Yongmao Liu Executive Vice President
You’re viewing 5 of 12 executive team members. Get the full list »

Shenogen Board Members (9)

Name Representing Role Since
Amy Tang Qiming Venture Partners Board Member 000 0000
Daqing Cai Ph.D Legend Capital Board Member 000 0000
Jianguang Li IDG Capital Board Member 000 0000
Kun Meng Ph.D Shenogen Co-Founder, Chief Executive Officer & Chairman 000 0000
Larry Zhang Ph.D Shenogen Chief Operating Officer, Chief Technology Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Shenogen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shenogen Investors (33)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boxin Capital PE/Buyout Minority 000 0000 000000 0
China Shandong Expressway Financial Group Corporation Minority 000 0000 000000 0
Flower City Ventures Venture Capital Minority 000 0000 000000 0
Guangzhou Fund Government Minority 000 0000 000000 0
Huaxi Securities Corporation Minority 000 0000 000000 0
You’re viewing 5 of 33 investors. Get the full list »

Shenogen Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000 31-Mar-2016 00000 00000 00 Pharmaceuticals
To view Shenogen’s complete investments history, request access »

Shenogen Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 000 31-Mar-2016 00000 00000 00 Completed
  • 2 buyers
To view Shenogen’s complete exits history, request access »